GOOD MANUFACTURING PRACTICE (GMP) GUIDELINE IN PHARMACEUTICAL INDUSTRIES: IMPLEMENTATION AND ITS SIGNIFICANCE FROM THE VIEW OF PHARMACISTS
Md. Mostafa Ahmed*, Arifa Sultana, Shah Jamil Bhuiyan, Fahima Akhter Purni, Nasiba Binte Bahar, Md. Rafat Tahsin, Ehfazul Haq, Sanzida Khondoker, Fahima Jannat Koly, Sadia Afrin, Tanzia Islam Tithi, Juhaer Anjum, Refaya Rezwan, Sonia Ferdousy,
ABSTRACT
Good manufacturing practice or GMP are regulations governed by the US Food and Drug Administration under the authority of the Federal Food, Drug, and Cosmetic Act. These regulations require that manufacturers, processors, and packagers of drugs take appropriate proactive steps to ensure that their products are safe, pure, and effective. GMP is also sporadically referred to as ?cGMP?. The ?c? stands for ?current?, reminding manufacturers that they have to employ technologies and systems that are up-to-date to cope with the regulations. Testing a small sample from a batch may not enough to ensure quality. So, it is significant that drugs are manufactured under controlled conditions to repeatedly meet consistent specifications required by the GMP regulations to assure that quality is built into the design and manufacturing process. We aimed to concentrate on the justification of the incorporation of GMP guidelines in the pharmaceutical industry from the perception of pharmacists.
[Full Text Article] [Certificate Download]
